Hormonal Management of Heavy Menstrual Bleeding in Adolescents

Launched by UNIVERSITY HOSPITAL, GENEVA · Dec 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well hormonal medications, like birth control pills, patches, and hormonal intra-uterine devices, help manage heavy menstrual bleeding in young women, both with and without bleeding disorders. The researchers want to find out if these treatments work similarly for both groups and how they affect quality of life, as well as levels of hemoglobin and iron in the blood, which are important for overall health.

To participate in the study, you need to be a female adolescent or young adult under 26 years old, experiencing heavy menstrual bleeding, and willing to start a hormonal treatment. However, if you are pregnant or planning to become pregnant, currently using hormonal medications, have certain uterine issues, or are taking blood-thinning medications, you won’t be eligible. If you join the trial, you can expect regular check-ins and support while the researchers track how well the treatment works for you. Your involvement could help improve future care for others with similar issues.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Adolescents and young adults aged \< 26yo
• • Presenting to the gynecology consultation at HUG
• • Diagnosed with heavy menstrual bleeding (PBAC \> 100)
• • Willing to initiate a hormonal medication to manage heavy menstrual bleeding
• Exclusion Criteria:
• • Pregnancy or planning to become pregnant during the study period
• • Already using hormonal medication for menstrual management and/or contraception
• • Known anatomical uterine pathology
• • Using anticoagulant or antiaggregant agents